vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Nextpower Inc. (NXT). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $909.4M, roughly 1.0× Nextpower Inc.). Nextpower Inc. runs the higher net margin — 14.4% vs 0.7%, a 13.7% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 33.9%). Nextpower Inc. produced more free cash flow last quarter ($118.5M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 11.1%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Nextpower Inc. (NXT) is a global energy technology provider based in Fremont, California.
ASTH vs NXT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $909.4M |
| Net Profit | $6.6M | $131.2M |
| Gross Margin | — | 31.7% |
| Operating Margin | 1.9% | 19.4% |
| Net Margin | 0.7% | 14.4% |
| Revenue YoY | 42.9% | 33.9% |
| Net Profit YoY | 184.4% | 13.8% |
| EPS (diluted) | $0.12 | $0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $909.4M | ||
| Q3 25 | $956.0M | $905.3M | ||
| Q2 25 | $654.8M | $864.3M | ||
| Q1 25 | $620.4M | $924.3M | ||
| Q4 24 | $665.2M | $679.4M | ||
| Q3 24 | $478.7M | $635.6M | ||
| Q2 24 | $486.3M | $719.9M | ||
| Q1 24 | $404.4M | $736.5M |
| Q4 25 | $6.6M | $131.2M | ||
| Q3 25 | $373.0K | $146.9M | ||
| Q2 25 | $9.4M | $157.2M | ||
| Q1 25 | $6.7M | $156.8M | ||
| Q4 24 | $-7.8M | $115.3M | ||
| Q3 24 | $16.1M | $115.4M | ||
| Q2 24 | $19.2M | $121.7M | ||
| Q1 24 | $14.8M | $205.2M |
| Q4 25 | — | 31.7% | ||
| Q3 25 | — | 32.4% | ||
| Q2 25 | — | 32.6% | ||
| Q1 25 | — | 33.1% | ||
| Q4 24 | — | 35.5% | ||
| Q3 24 | — | 35.4% | ||
| Q2 24 | — | 33.0% | ||
| Q1 24 | — | 46.2% |
| Q4 25 | 1.9% | 19.4% | ||
| Q3 25 | 2.0% | 20.0% | ||
| Q2 25 | 3.1% | 21.5% | ||
| Q1 25 | 3.3% | 21.1% | ||
| Q4 24 | 0.1% | 22.1% | ||
| Q3 24 | 5.9% | 21.0% | ||
| Q2 24 | 6.2% | 22.2% | ||
| Q1 24 | 7.5% | 36.8% |
| Q4 25 | 0.7% | 14.4% | ||
| Q3 25 | 0.0% | 16.2% | ||
| Q2 25 | 1.4% | 18.2% | ||
| Q1 25 | 1.1% | 17.0% | ||
| Q4 24 | -1.2% | 17.0% | ||
| Q3 24 | 3.4% | 18.2% | ||
| Q2 24 | 3.9% | 16.9% | ||
| Q1 24 | 3.7% | 27.9% |
| Q4 25 | $0.12 | $0.85 | ||
| Q3 25 | $0.01 | $0.97 | ||
| Q2 25 | $0.19 | $1.04 | ||
| Q1 25 | $0.14 | $1.05 | ||
| Q4 24 | $-0.14 | $0.79 | ||
| Q3 24 | $0.33 | $0.79 | ||
| Q2 24 | $0.40 | $0.84 | ||
| Q1 24 | $0.31 | $1.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $952.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $2.2B |
| Total Assets | $2.2B | $3.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $952.6M | ||
| Q3 25 | $463.4M | $845.3M | ||
| Q2 25 | $342.1M | $743.4M | ||
| Q1 25 | $260.9M | $766.1M | ||
| Q4 24 | $290.8M | $693.5M | ||
| Q3 24 | $350.3M | $561.9M | ||
| Q2 24 | $327.7M | $471.9M | ||
| Q1 24 | $337.3M | $474.1M |
| Q4 25 | $779.3M | $2.2B | ||
| Q3 25 | $775.5M | $2.0B | ||
| Q2 25 | $765.5M | $1.8B | ||
| Q1 25 | $745.4M | $1.6B | ||
| Q4 24 | $712.7M | $1.4B | ||
| Q3 24 | $704.6M | $1.3B | ||
| Q2 24 | $678.9M | $1.1B | ||
| Q1 24 | $653.5M | $961.0M |
| Q4 25 | $2.2B | $3.8B | ||
| Q3 25 | $2.2B | $3.7B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.3B | $3.2B | ||
| Q4 24 | $1.4B | $3.0B | ||
| Q3 24 | $1.3B | $2.8B | ||
| Q2 24 | $1.3B | $2.6B | ||
| Q1 24 | $1.2B | $2.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $123.3M |
| Free Cash FlowOCF − Capex | $-6.0M | $118.5M |
| FCF MarginFCF / Revenue | -0.6% | 13.0% |
| Capex IntensityCapex / Revenue | 0.3% | 0.5% |
| Cash ConversionOCF / Net Profit | -0.44× | 0.94× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $587.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $123.3M | ||
| Q3 25 | $10.0M | $186.9M | ||
| Q2 25 | $90.9M | $81.3M | ||
| Q1 25 | $16.6M | $237.3M | ||
| Q4 24 | $-10.9M | $143.8M | ||
| Q3 24 | $34.0M | $153.8M | ||
| Q2 24 | $23.2M | $120.8M | ||
| Q1 24 | $6.0M | $111.5M |
| Q4 25 | $-6.0M | $118.5M | ||
| Q3 25 | $7.4M | $171.4M | ||
| Q2 25 | $89.5M | $70.1M | ||
| Q1 25 | $13.6M | $227.2M | ||
| Q4 24 | $-13.5M | $134.9M | ||
| Q3 24 | $31.7M | $141.8M | ||
| Q2 24 | $20.4M | $118.0M | ||
| Q1 24 | $5.6M | $109.2M |
| Q4 25 | -0.6% | 13.0% | ||
| Q3 25 | 0.8% | 18.9% | ||
| Q2 25 | 13.7% | 8.1% | ||
| Q1 25 | 2.2% | 24.6% | ||
| Q4 24 | -2.0% | 19.9% | ||
| Q3 24 | 6.6% | 22.3% | ||
| Q2 24 | 4.2% | 16.4% | ||
| Q1 24 | 1.4% | 14.8% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.3% | 1.7% | ||
| Q2 25 | 0.2% | 1.3% | ||
| Q1 25 | 0.5% | 1.1% | ||
| Q4 24 | 0.4% | 1.3% | ||
| Q3 24 | 0.5% | 1.9% | ||
| Q2 24 | 0.6% | 0.4% | ||
| Q1 24 | 0.1% | 0.3% |
| Q4 25 | -0.44× | 0.94× | ||
| Q3 25 | 26.69× | 1.27× | ||
| Q2 25 | 9.65× | 0.52× | ||
| Q1 25 | 2.48× | 1.51× | ||
| Q4 24 | — | 1.25× | ||
| Q3 24 | 2.11× | 1.33× | ||
| Q2 24 | 1.21× | 0.99× | ||
| Q1 24 | 0.40× | 0.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
NXT
| Transferred Over Time | $763.9M | 84% |
| Transferred At Point In Time | $145.4M | 16% |
